Yield10 Bioscience, Inc.
YTEN · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $60 | $450 | $614 | $799 |
| % Growth | -86.7% | -26.7% | -23.2% | – |
| Cost of Goods Sold | $290 | $656 | $578 | $5,220 |
| Gross Profit | -$230 | -$206 | $36 | -$4,421 |
| % Margin | -383.3% | -45.8% | 5.9% | -553.3% |
| R&D Expenses | $8,323 | $7,750 | $6,201 | $5,361 |
| G&A Expenses | $6,154 | $6,151 | $6,105 | $5,047 |
| SG&A Expenses | $6,154 | $6,151 | $6,105 | $5,047 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $41 | -$3 | $83 |
| Operating Expenses | $14,477 | $13,901 | $12,306 | $10,408 |
| Operating Income | -$14,417 | -$13,451 | -$11,692 | -$9,609 |
| % Margin | -24,028.3% | -2,989.1% | -1,904.2% | -1,202.6% |
| Other Income/Exp. Net | -$38 | $41 | $697 | -$541 |
| Pre-Tax Income | -$14,455 | -$13,410 | -$10,995 | -$10,150 |
| Tax Expense | $0 | $156 | $36 | $56 |
| Net Income | -$14,455 | -$13,566 | -$11,031 | -$10,206 |
| % Margin | -24,091.7% | -3,014.7% | -1,796.6% | -1,277.3% |
| EPS | -43.66 | -66.25 | -55.95 | -103.21 |
| % Growth | 34.1% | -18.4% | 45.8% | – |
| EPS Diluted | -43.66 | -66.25 | -55.95 | -103.21 |
| Weighted Avg Shares Out | 331 | 205 | 197 | 99 |
| Weighted Avg Shares Out Dil | 331 | 205 | 197 | 99 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $290 | $656 | $578 | $611 |
| EBITDA | -$14,127 | -$13,188 | -$11,472 | -$9,427 |
| % Margin | -23,545% | -2,930.7% | -1,868.4% | -1,179.8% |